Prothena Corporation plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
Roche, Prothena Off To PhII With Their Disease-Modifying Parkinson’s Drug
Article By: Lorimer Wilson
Monday, April 3, 2017 5:41 AM EST
Prothena turned up at the big Alzheimer’s/Parkinson’s conference in Vienna this weekend and presented early-stage data showing how its Roche-partnered drug PRX002/RG7935 can flush out toxic clusters of alpha-synuclein in Parkinson’s patients.
In this article: PRTA Also: PRAN, ACIU
Read
Prothena Announces Pricing Of Public Offering Of 2,700,000 Ordinary Shares
Article By: NASDAQ GlobeNewswire
Friday, March 3, 2017 3:15 PM EST
Prothena Corporation plc today announced that it has sold 2,700,000 of its ordinary shares at a price to the public of $57.50 per ordinary share.
In this article: PRTA
Read
Prothena - Chart Of The Day
Article By: Jim Van Meerten
Thursday, July 16, 2015 8:33 PM EST
Since the Trend Spotter signaled a buy on 5/29 the stock gained 48.38%.
In this article: PRTA
Read
5 Stocks Leading XBI Biotech ETF Higher
Article By: Sweta Killa
Friday, June 26, 2015 6:51 AM EST
With an AUM of $2.3 billion and average daily volume of close to a million shares, XBI is extremely liquid and an easily traded fund. It provides equal weight exposure across 106 stocks by tracking the S&P Biotechnology Select Industry Index.
In this article: XBI, EGRX, HRTX, EXEL, RTRX, PRTA
Read
5 Promising Biotech Recommendations Revisited
Article By: Bret Jensen
Monday, June 1, 2015 7:07 AM EST
The small biotech sector is one of the most volatile sectors of the market. A successful trial result can produce up to 100% gains in a day; a disappointing result which happens all too often can crater the stock of the company by just as much.
In this article: AGEN, AVEO, PRTA, CRIS, ZGNX Also: GSK, PTX
Read

PARTNER HEADLINES

Latest Tweets for $PRTA

No tweets yet!